citalopram and risperidone

citalopram has been researched along with risperidone in 74 studies

Research

Studies (74)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	37 (50.00)	29.6817
2010's	34 (45.95)	24.3611
2020's	3 (4.05)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Keserü, GM	1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	1
Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H	1
Lombardo, F; Obach, RS; Waters, NJ	1
Jia, L; Sun, H	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Ahman, M; Holmén, AG; Wan, H	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Sen, S; Sinha, N	1
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B	1
Doran, AC; Mancuso, JY; Osgood, SM; Shaffer, CL	1
Andreasson, T; Mattsson, C; Sonesson, C; Waters, N	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
He, Y; Liu, Y; Shen, J; Shi, W; Wang, Y; Wang, Z; Wu, C; Wu, S; Yang, F; Zheng, W	1
Miller, LJ	1
Aberg, LE; Aronen, ET; Bäckman, ML; Santavuori, PR	1
Dagerman, KS; Davis, KL; Davis, S; Hsiao, JK; Jeste, DV; Katz, IR; Lebowitz, B; Lieberman, JA; Lyketsos, CG; Olin, JT; Pollock, BG; Rabins, PV; Rosenheck, RA; Schneider, LS; Small, GW; Tariot, PN	1
Freudenreich, O	1
Keller, R; Mongini, F	1
Coffey, B; Gabbay, V	1
Cassano, GB; Danesi, R; Del Tacca, M; Dell'osso, L; Di Paolo, A; Lastella, M; Lattanzi, L; Menichetti, F; Mungai, F	1
Baker, EH; Khattak, H; Kothari, P; Lancaster, D; Scharko, AM	1
Kozian, R	1
Goldman, S	1
Bleich, S; Hillemacher, T; Kropp, S; Ziegenbein, M	1
Dai, J; Huang, M; Ichiwaka, J; Li, Z; Meltzer, HY	1
Bossie, CA; Bouhours, P; Canuso, CM; Dunbar, F; Gharabawi, GM; Keller, MB; Lasser, RA; Loescher, A; Mahmoud, RA; Nemeroff, CB; Rapaport, MH; Turkoz, I	1
Kapetanovic, S; Simpson, GM	1
Marlowe, K; Schirgel, D	1
Blier, P; Dremencov, E; El Mansari, M	2
Alacqua, M; Arcoraci, V; Calarese, T; Di Vita, G; Gagliano, C; Germanò, E; Magazù, A; Spina, E; Trifirò, G	1
Arnt, J; Bang-Andersen, B; Brennum, LT; Christoffersen, CT; Di Matteo, V; Didriksen, M; Esposito, E; Hertel, P; Larsen, AK; Marcus, MM; Pouzet, B; Ramirez, T; Svensson, TH; Søby, KK	1
Blakesley, RE; Houck, PR; Huber, KA; Mazumdar, S; Mulsant, BH; Pollock, BG; Rosen, J	1
Barzó, P; Janka, Z; Kálmán, J; Sas, K; Szakács, R	1
Alexopoulos, GS; Bossie, CA; Canuso, CM; Gharabawi, GM; Greenspan, A; Reynolds, C; Turkoz, I	1
Blaschke, D; Boldt, LH; Dietz, R; Haverkamp, W; Huemer, M; Parwani, AS; Rolf, S	1
Frölich, L; Schulte-Brochterbeck, G; Waltereit, R; Wiltfang, J	1
Deb, S; Unwin, GL	1
Kessler, H; Kraft, S	1
Preuss, UW; Wustmann, T	1
Bhan-Kotwal, S; Carmaciu, CD; Jenkins, HS; Koul, S	1
Dombrovski, AY; Ferrell, RE; Houck, PR; Lotrich, FE; Mazumdar, S; Mulsant, BH; Pollock, BG; Rosen, JI; Wallace, M	1
Wijdicks, EF; Yee, AH	1
Adunuri, N; Gill, SS; Gruneir, A; Herrmann, N; Rochon, P; Seitz, DP	1
Bruzek, JL; Jerome, RN; Krishnaswami, S; McPheeters, ML; Sathe, N; Veenstra-Vanderweele, J; Warren, Z	1
Barak, Y; Paleacu, D; Plopski, I; Tadger, S	1
Bundgaard, C; Garmer, M; Jensen, CJ	1
Gertow, J; Jardemark, K; Konradsson-Geuken, A; Malmerfelt, A; Marcus, MM; Svensson, TH	1
Emeremni, CA; Houck, PR; Ismail, Z; Mazumdar, S; Mulsant, BH; Pollock, BG; Rajji, TK; Rosen, J	1
Hsueh, JH; Huang, CC; Lu, YY; Wei, IH	1
Andrews, G; Boulton, M; Michael, S	1
Bernardo, M; Caballero, M; Corripio, I; Felipe, AE; Fernandez de Corres, B; González Piqueras, JC; Huerta, R; Ibáñez, A; Iniesta, R; López-Carrilero, R; Oliveira, C; Roca, M; Rodriguez-Jimenez, R; Sindreu, SD; Usall, J	1
Kamińska, K; Rogóż, Z	3
Mermelstein, AC; Mermelstein, J	1
Björkholm, C; Feltmann, K; Jardemark, K; Konradsson-Geuken, Å; Malmerfelt, A; Marcus, MM; Möller, A; Påhlsson, N; Schilström, B; Svensson, TH	1
Górska, A; Gołembiowska, K; Jurczak, A; Kamińska, K; Noworyta-Sokołowska, K; Rogóż, Z	1
Bonse, A; Hempel, G; Lingg, R; Oberfeld, S; Telger, K; Weber, J	1
Kamińska, K; Pańczyszyn-Trzewik, P; Rogóż, Z; Sowa-Kućma, M	1
Bewley, A; Mohandas, P; Taylor, R	1
Abdel-Gawad, NM; Gharbaoui, Y; Pigott, TA; Teixeira, AL; Wu, HE	1
Górska, A; Gołembiowska, K; Kamińska, K; Noworyta-Sokołowska, K; Rogóż, Z; Wojtas, A	1
Cheng, X; Dong, W; Feng, W; Li, H; Wang, M; Zhang, D	1
Chen, A; Cloutier, A; Copeli, F; Metzger, E; Osser, DN	1

Reviews

6 review(s) available for citalopram and risperidone

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[Neuropsychiatric symptoms in Sotos syndrome. Case report and review of the literature]. Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 2008, Volume: 22, Issue:1 Topics: Adult; Antipsychotic Agents; Brain; Carbamazepine; Chromosome Deletion; Citalopram; Compulsive Behavior; Craniofacial Abnormalities; Drug Therapy, Combination; Facies; Female; Gigantism; Hallucinations; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Humans; Intracellular Signaling Peptides and Proteins; Learning Disabilities; Neurocognitive Disorders; Neuropsychological Tests; Nuclear Proteins; Risperidone; Selective Serotonin Reuptake Inhibitors; Syndrome	2008
[Turner-syndrome and psychosis: a case report and brief review of the literature]. Psychiatrische Praxis, 2009, Volume: 36, Issue:5 Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Chromosome Aberrations; Citalopram; Combined Modality Therapy; Drug Therapy, Combination; Female; Hallucinations; Humans; Middle Aged; Olanzapine; Patient Education as Topic; Psychotherapy; Psychotic Disorders; Risperidone; Turner Syndrome	2009
Antidepressants for agitation and psychosis in dementia. The Cochrane database of systematic reviews, 2011, Feb-16, Issue:2 Topics: Adult; Antidepressive Agents; Citalopram; Dementia; Humans; Psychomotor Agitation; Psychotic Disorders; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Trazodone	2011
A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics, 2011, Volume: 127, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Child; Child Development Disorders, Pervasive; Child, Preschool; Citalopram; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Female; Fluoxetine; Humans; Male; Patient Compliance; Piperazines; Prognosis; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Serotonin Antagonists; Severity of Illness Index; Treatment Outcome	2011
The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on management of behavioral and psychological symptoms in dementia. Psychiatry research, 2021, Volume: 295 Topics: Academic Medical Centers; Aged; Algorithms; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Citalopram; Dementia; Electroconvulsive Therapy; Haloperidol; Humans; Olanzapine; Psychopharmacology; Risperidone	2021

Trials

9 trial(s) available for citalopram and risperidone

Article	Year
New antidepressive and antipsychotic drugs in juvenile neuronal ceroid lipofuscinoses--a pilot study. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2001, Volume: 5 Suppl A Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Child; Citalopram; Dibenzothiazepines; Female; Humans; Male; Neuronal Ceroid-Lipofuscinoses; Olanzapine; Pilot Projects; Pirenzepine; Quetiapine Fumarate; Risperidone	2001
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2001,Fall, Volume: 9, Issue:4 Topics: Aged; Algorithms; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Citalopram; Cost-Benefit Analysis; Humans; Olanzapine; Patient Compliance; Pirenzepine; Psychomotor Agitation; Psychotic Disorders; Risperidone; Treatment Outcome	2001
Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Chi-Square Distribution; Citalopram; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Drug Resistance; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Proportional Hazards Models; Risperidone; Selective Serotonin Reuptake Inhibitors; Time Factors	2006
A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2007, Volume: 15, Issue:11 Topics: Aged, 80 and over; Antipsychotic Agents; Citalopram; Dementia; Double-Blind Method; Female; Hospitalization; Humans; Male; Patient Dropouts; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2007
Placebo-controlled study of relapse prevention with risperidone augmentation in older patients with resistant depression. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2008, Volume: 16, Issue:1 Topics: Aged; Aged, 80 and over; Citalopram; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prospective Studies; Regression Analysis; Risperidone; Secondary Prevention; Serotonin Antagonists	2008
Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms. International clinical psychopharmacology, 2010, Volume: 25, Issue:1 Topics: Aged; Aged, 80 and over; Alleles; Antipsychotic Agents; Behavioral Symptoms; Citalopram; Dementia; Female; Genotype; Humans; Male; Polymorphism, Genetic; Psychotic Disorders; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Treatment Outcome	2010
Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot study. International psychogeriatrics, 2011, Volume: 23, Issue:9 Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Citalopram; Double-Blind Method; Female; Humans; Male; Psychotic Disorders; Risperidone; Treatment Outcome	2011
A comparison of the E-BEHAVE-AD, NBRS, and NPI in quantifying clinical improvement in the treatment of agitation and psychosis associated with dementia. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2013, Volume: 21, Issue:1 Topics: Aged, 80 and over; Citalopram; Dementia; Double-Blind Method; Female; Humans; Male; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Risperidone; ROC Curve; Symptom Assessment	2013
Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia. The Journal of clinical psychiatry, 2014, Volume: 75, Issue:6 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Citalopram; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Morpholines; Olanzapine; Psychiatric Status Rating Scales; Reboxetine; Risperidone; Schizophrenia; Schizophrenic Psychology	2014

Other Studies

59 other study(ies) available for citalopram and risperidone

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods. Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16 Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship	2003
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery. Journal of medicinal chemistry, 2007, Sep-20, Volume: 50, Issue:19 Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Support vector machines classification of hERG liabilities based on atom types. Bioorganic & medicinal chemistry, 2008, Jun-01, Volume: 16, Issue:11 Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve	2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs. Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6 Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model. European journal of medicinal chemistry, 2011, Volume: 46, Issue:2 Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship	2011
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment. Journal of applied toxicology : JAT, 2012, Volume: 32, Issue:10 Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers	2012
An evaluation of using rat-derived single-dose neuropharmacokinetic parameters to project accurately large animal unbound brain drug concentrations. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:11 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain; Brain Chemistry; Dogs; Isoxazoles; Male; Paliperidone Palmitate; Primates; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Thiophenes	2012
Systematic in vivo screening of a series of 1-propyl-4-arylpiperidines against dopaminergic and serotonergic properties in rat brain: a scaffold-jumping approach. Journal of medicinal chemistry, 2012, Nov-26, Volume: 55, Issue:22 Topics: Animals; Behavior, Animal; Brain; Dopamine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Locomotion; Molecular Structure; Psychotic Disorders; Rats; Serotonin; Serotonin Receptor Agonists; Structure-Activity Relationship	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Synthesis and biological investigation of triazolopyridinone derivatives as potential multireceptor atypical antipsychotics. Bioorganic & medicinal chemistry letters, 2020, 04-15, Volume: 30, Issue:8 Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Pyridines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Structure-Activity Relationship; Triazoles	2020
Withdrawal-emergent dyskinesia in a patient taking risperidone/citalopram. The Annals of pharmacotherapy, 2000, Volume: 34, Issue:2 Topics: Aged; Aged, 80 and over; Antidepressive Agents; Antipsychotic Agents; Citalopram; Dopamine Antagonists; Female; Humans; Risperidone; Substance Withdrawal Syndrome	2000
Exacerbation of idiopathic priapism with risperidone-citalopram combination. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:3 Topics: Adrenergic Antagonists; Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Citalopram; Depressive Disorder, Major; Drug Synergism; Drug Therapy, Combination; Humans; Male; Priapism; Recurrence; Risperidone; Schizophrenia, Paranoid; Selective Serotonin Reuptake Inhibitors	2002
Switch to quetiapine in antipsychotic agent-related hyperprolactinemia. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2002, Volume: 23, Issue:5 Topics: Adolescent; Adult; Antipsychotic Agents; Citalopram; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Prolactin; Psychotic Disorders; Quetiapine Fumarate; Risperidone	2002
Obsessive-Compulsive disorder, Tourette's disorder, or pediatric autoimmune neuropsychiatric disorders associated with Streptococcus in an adolescent? Diagnostic and therapeutic challenges. Journal of child and adolescent psychopharmacology, 2003,Fall, Volume: 13, Issue:3 Topics: Adolescent; Antipsychotic Agents; Autoimmune Diseases; Citalopram; Clinical Laboratory Techniques; Diagnosis, Differential; Humans; Interview, Psychological; Male; Mental Disorders; Obsessive-Compulsive Disorder; Risperidone; Selective Serotonin Reuptake Inhibitors; Streptococcal Infections; Tourette Syndrome	2003
Genotype A1/A2 associated with neuroleptic malignant syndrome. Bipolar disorders, 2005, Volume: 7, Issue:4 Topics: Adult; Alleles; Antipsychotic Agents; Citalopram; Depressive Disorder, Major; DNA Primers; Humans; Male; Neuroleptic Malignant Syndrome; Polymerase Chain Reaction; Receptors, Dopamine D2; Risperidone; Selective Serotonin Reuptake Inhibitors	2005
Case study: delirium in an adolescent girl with human immunodeficiency virus-associated dementia. Journal of the American Academy of Child and Adolescent Psychiatry, 2006, Volume: 45, Issue:1 Topics: Adolescent; AIDS Dementia Complex; Antipsychotic Agents; Brain; Citalopram; Delirium; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; Neurologic Examination; Risperidone	2006
[Brief case report. Duloxetine in Cotard syndrome]. Psychiatrische Praxis, 2005, Volume: 32, Issue:8 Topics: Affective Disorders, Psychotic; Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Citalopram; Delusions; Depersonalization; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Long-Term Care; Olanzapine; Risperidone; Syndrome; Thiophenes	2005
Possible antipsychotic effect of fluvoxamine. CNS spectrums, 2005, Volume: 10, Issue:10 Topics: Antipsychotic Agents; Citalopram; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Injections, Intramuscular; Middle Aged; Psychotic Disorders; Risperidone	2005
Genetic predisposition to neuroleptic malignant syndrome in siblings. The Annals of pharmacotherapy, 2006, Volume: 40, Issue:3 Topics: Adult; Antipsychotic Agents; Citalopram; Female; Humans; Male; Neuroleptic Malignant Syndrome; Polymorphism, Genetic; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors	2006
Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex. Psychopharmacology, 2006, Volume: 185, Issue:3 Topics: Animals; Antipsychotic Agents; Citalopram; Dopamine; Drug Synergism; Male; Norepinephrine; Piperazines; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Antagonists	2006
Delirium in HIV-associated dementia. Journal of the American Academy of Child and Adolescent Psychiatry, 2006, Volume: 45, Issue:7 Topics: Adolescent; AIDS Dementia Complex; Antipsychotic Agents; Brain; Citalopram; Cytochrome P-450 CYP2D6 Inhibitors; Delirium; Drug Interactions; Female; HIV Protease Inhibitors; Humans; Risperidone; Ritonavir; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome	2006
Quetiapine and citalopram: aetiological significances in serotonin syndrome. The New Zealand medical journal, 2006, Jul-07, Volume: 119, Issue:1237 Topics: Adult; Alprazolam; Anti-Anxiety Agents; Antipsychotic Agents; Bipolar Disorder; Citalopram; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Syndrome; Treatment Outcome	2006
Noradrenergic augmentation of escitalopram response by risperidone: electrophysiologic studies in the rat brain. Biological psychiatry, 2007, Mar-01, Volume: 61, Issue:5 Topics: Action Potentials; Analysis of Variance; Animals; Antipsychotic Agents; Brain; Citalopram; Drug Synergism; Male; Neurons; Norepinephrine; Rats; Rats, Sprague-Dawley; Risperidone	2007
Distinct electrophysiological effects of paliperidone and risperidone on the firing activity of rat serotonin and norepinephrine neurons. Psychopharmacology, 2007, Volume: 194, Issue:1 Topics: Adrenergic Uptake Inhibitors; Animals; Antipsychotic Agents; Citalopram; Desipramine; Dose-Response Relationship, Drug; Electrophysiology; Infusion Pumps; Injections, Intravenous; Isoxazoles; Male; Neurons; Norepinephrine; Paliperidone Palmitate; Piperazines; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists	2007
Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting. Pharmacy world & science : PWS, 2008, Volume: 30, Issue:1 Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Child; Citalopram; Drug Utilization Review; Female; Fluoxetine; Humans; Hyperprolactinemia; Italy; Male; Medical Records; Mental Disorders; Olanzapine; Paroxetine; Practice Patterns, Physicians'; Retrospective Studies; Risperidone; Sertraline; Treatment Outcome	2008
Lu 35-138 ((+)-(S)-3-{1-[2-(1-acetyl-2,3-dihydro-1H-indol-3-yl)ethyl]-3,6-dihydro-2H-pyridin-4-yl}-6-chloro-1H-indole), a dopamine D4 receptor antagonist and serotonin reuptake inhibitor: characterisation of its in vitro profile and pre-clinical antipsych European journal of pharmacology, 2007, Nov-14, Volume: 573, Issue:1-3 Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Animals, Outbred Strains; Benzodiazepines; Cebus; Citalopram; Clozapine; Cognition; Dihydropyridines; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Haloperidol; Haplorhini; Humans; Indoles; Male; Mice; Molecular Structure; Motor Activity; Olanzapine; Piperazines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Dopamine D4; Risperidone; Selective Serotonin Reuptake Inhibitors; Sulfonamides	2007
[Amnesic syndrome following lesion of the fornix or does reversible Korsakow's syndrome exist?]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2007, Volume: 9, Issue:1 Topics: Amnesia, Anterograde; Citalopram; Donepezil; Female; Fornix, Brain; Humans; Indans; Intracranial Aneurysm; Korsakoff Syndrome; Middle Aged; Neurosurgical Procedures; Nootropic Agents; Piperidines; Risperidone; Rupture, Spontaneous; Subarachnoid Hemorrhage; Vasospasm, Intracranial	2007
Torsade de pointes during combined treatment with risperidone and citalopram. Pharmacopsychiatry, 2007, Volume: 40, Issue:6 Topics: Aged; Antipsychotic Agents; Citalopram; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Humans; Long QT Syndrome; Risperidone; Selective Serotonin Reuptake Inhibitors; Torsades de Pointes	2007
AIDS dementia complex and Hashimoto encephalopathy in a senescent woman. International journal of geriatric psychiatry, 2007, Volume: 22, Issue:12 Topics: Aged; AIDS Dementia Complex; Antipsychotic Agents; Citalopram; Female; Hashimoto Disease; Humans; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2007
Use of medication for the management of behavior problems among adults with intellectual disabilities: a clinicians' consensus survey. American journal of mental retardation : AJMR, 2008, Volume: 113, Issue:1 Topics: Adult; Aggression; Antipsychotic Agents; Attitude of Health Personnel; Autistic Disorder; Carbamazepine; Child; Citalopram; Consensus; Humans; Mental Disorders; Risperidone; Self-Injurious Behavior; Surveys and Questionnaires	2008
Organic psychosis induced by ofloxacin and metronidazole. British journal of hospital medicine (London, England : 2005), 2009, Volume: 70, Issue:4 Topics: Adolescent; Anti-Infective Agents; Antipsychotic Agents; Citalopram; Drug Therapy, Combination; Female; Humans; Metronidazole; Ofloxacin; Psychoses, Substance-Induced; Risperidone; Treatment Outcome; Urinary Tract Infections	2009
A perfect storm in the emergency department. Neurocritical care, 2010, Volume: 12, Issue:2 Topics: Aged; Alzheimer Disease; Citalopram; Drug Therapy, Combination; Female; Humans; Iatrogenic Disease; Myoclonus; Psychomotor Agitation; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome	2010
Species comparison of in vivo P-glycoprotein-mediated brain efflux using mdr1a-deficient rats and mice. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:3 Topics: Animals; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain; Citalopram; Cyclohexanols; Gene Knockout Techniques; Genotype; Mice; Piperazines; Quinolones; Rats; Risperidone; Species Specificity; Venlafaxine Hydrochloride	2012
Augmentation by escitalopram, but not citalopram or R-citalopram, of the effects of low-dose risperidone: behavioral, biochemical, and electrophysiological evidence. Synapse (New York, N.Y.), 2012, Volume: 66, Issue:4 Topics: Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Brain; Chromatography, High Pressure Liquid; Citalopram; Dopamine; Drug Synergism; Drug Therapy, Combination; Electrophysiological Phenomena; Male; Microdialysis; Patch-Clamp Techniques; Rats; Rats, Wistar; Risperidone; Selective Serotonin Reuptake Inhibitors	2012
Delirium caused by a drug-drug interaction between bupropion and risperidone. Journal of clinical psychopharmacology, 2014, Volume: 34, Issue:1 Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bipolar Disorder; Bupropion; Citalopram; Delirium; Drug Interactions; Drug Substitution; Drug Therapy, Combination; Humans; Male; Middle Aged; Risperidone; Treatment Outcome	2014
Two cases of olfactory reference syndrome responding to an atypical antipsychotic and SSRI. The Australian and New Zealand journal of psychiatry, 2014, Volume: 48, Issue:9 Topics: Adult; Antipsychotic Agents; Aripiprazole; Citalopram; Delusions; Drug Therapy, Combination; Female; Hallucinations; Humans; Male; Piperazines; Quinolones; Risperidone; Selective Serotonin Reuptake Inhibitors; Young Adult	2014
The effect of combined treatment with risperidone and antidepressants on the MK-801-induced deficits in the social interaction test in rats. Pharmacological reports : PR, 2015, Volume: 67, Issue:6 Topics: Animals; Antidepressive Agents; Citalopram; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Synergism; Male; Mianserin; Mirtazapine; Rats; Risperidone; Social Behavior	2015
Rhabdomyolysis With Risperidone and Escitalopram Coadministration: A Case Report. Journal of clinical psychopharmacology, 2016, Volume: 36, Issue:1 Topics: Adult; Antipsychotic Agents; Citalopram; Drug Interactions; Humans; Male; Rhabdomyolysis; Risperidone; Selective Serotonin Reuptake Inhibitors	2016
The effect of combined treatment with escitalopram and risperidone on the MK-801-induced changes in the object recognition test in mice. Pharmacological reports : PR, 2016, Volume: 68, Issue:1 Topics: Animals; Antipsychotic Agents; Citalopram; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Exploratory Behavior; Male; Memory Disorders; Mice; Recognition, Psychology; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2016
Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2016, Volume: 26, Issue:9 Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Antidepressive Agents; Antipsychotic Agents; Benzamides; Bridged Bicyclo Compounds; Citalopram; Depression; Disease Models, Animal; Dopamine; Excitatory Amino Acid Agonists; Male; N-Methylaspartate; Nicotinic Agonists; Phenylurea Compounds; Prefrontal Cortex; Pyramidal Cells; Rats, Sprague-Dawley; Rats, Wistar; Risperidone; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors	2016
The antidepressant- and anxiolytic-like effects following co-treatment with escitalopram and risperidone in rats. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2016, Volume: 67, Issue:3 Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents; Anxiety; Behavior, Animal; Citalopram; Depression; Drug Therapy, Combination; Exploratory Behavior; Male; Motor Activity; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Risperidone	2016
Risperidone and escitalopram co-administration: A potential treatment of schizophrenia symptoms with less side effects. Pharmacological reports : PR, 2017, Volume: 69, Issue:1 Topics: Animals; Antipsychotic Agents; Citalopram; Dopamine; Drug Therapy, Combination; Male; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Wistar; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin; Treatment Outcome	2017
Validation of a dried blood spot method for therapeutic drug monitoring of citalopram, mirtazapine and risperidone and its active metabolite 9-hydroxyrisperidone using HPLC-MS. Journal of pharmaceutical and biomedical analysis, 2017, Jun-05, Volume: 140 Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Citalopram; Dried Blood Spot Testing; Drug Monitoring; Humans; Mianserin; Mirtazapine; Paliperidone Palmitate; Reproducibility of Results; Risperidone; Tandem Mass Spectrometry	2017
Repeated co-treatment with antidepressants and risperidone increases BDNF mRNA and protein levels in rats. Pharmacological reports : PR, 2017, Volume: 69, Issue:5 Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Drug Interactions; Fluoxetine; Frontal Lobe; Gene Expression Regulation; Hippocampus; Mianserin; Mirtazapine; Rats; Rats, Wistar; Risperidone; RNA, Messenger; Serotonin Antagonists	2017
Morgellons disease: experiences of an integrated multidisciplinary dermatology team to achieve positive outcomes. The Journal of dermatological treatment, 2018, Volume: 29, Issue:2 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Local; Antipsychotic Agents; Anxiety; Citalopram; Depressive Disorder; Female; Humans; Male; Middle Aged; Morgellons Disease; Retrospective Studies; Risperidone; Treatment Outcome	2018
An Unusual Case of Acute Psychosis With Obsessive-Compulsive Features Following Arsenic Poisoning. Journal of psychiatric practice, 2017, Volume: 23, Issue:5 Topics: Adult; Antipsychotic Agents; Arsenic Poisoning; Citalopram; Humans; Male; Obsessive-Compulsive Disorder; Occupational Exposure; Psychotic Disorders; Risperidone; Selective Serotonin Reuptake Inhibitors	2017
The effect of chronic co-treatment with risperidone and novel antidepressant drugs on the dopamine and serotonin levels in the rats frontal cortex. Pharmacological reports : PR, 2018, Volume: 70, Issue:5 Topics: Animals; Antidepressive Agents; Catalepsy; Citalopram; Dopamine; Drug Synergism; Frontal Lobe; Locomotion; Male; Mianserin; Mirtazapine; Rats; Recognition, Psychology; Risperidone; Serotonin	2018
A UPLC-MS/MS Assay for Simultaneous Determination of Two Antipsychotics and Two Antidepressants in Human Plasma and Its Application in Clinic. Current pharmaceutical biotechnology, 2020, Volume: 21, Issue:1 Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Chromatography, High Pressure Liquid; Citalopram; Drug Monitoring; Fluoxetine; Humans; Risperidone; Tandem Mass Spectrometry	2020